ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 54

A Metagenome-wide Association Study of Gut Microbiome Revealed Novel Etiology of Rheumatoid Arthritis in the Japanese Population

Toshihiro Kishikawa 1, Yuichi Maeda 2, Takuro Nii 1, Daisuke Motooka 1, Yuki Matsumoto 1, Masato Matsushita 3, Hidetoshi Matsuoka 4, Maiko Yoshimura 4, Shoji Kawada 5, Satoru Teshigawara 4, Eri Oguro 1, Yasutaka Okita 4, Keisuke Kawamoto 5, Shinji Higa 6, Toru Hirano 7, Masashi Narazaki 1, Atsushi Ogata 5, Yukihiko Saeki 8, Shota Nakamura 1, Hidenori Inohara 1, Atsushi Kumanogoh 1, Kiyoshi Takeda 1 and Yukinori Okada1, 1Osaka University, Suita, Japan, 2Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan, 3Saiseikai Senri Hospital, Suita, Japan, 4NHO Osaka Minami Medical Center, Kawachinagano, Japan, 5Daini Osaka Police Hospital, Tennoji-ku, Japan, 6Osaka Second Police Hospital, Osaka, Japan, 7Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan, 8NHO Osaka Minami Medical Center, Kawachinagano, Osaka, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Microbiome and rheumatoid arthritis, pathogenesis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The causality and pathogenic mechanism of microbiome composition remain elusive in many diseases, including autoimmune diseases such as rheumatoid arthritis (RA). This study aimed to elucidate gut microbiome’s role in RA pathology by a comprehensive metagenome-wide association study (MWAS).

Methods: We conducted MWAS of the RA gut microbiome in the Japanese population (ncase = 82, ncontrol = 42) by utilizing whole-genome shotgun sequencing of high depth (average 13 Gb per sample). Our MWAS consisted of three major bioinformatic analytic pipelines (phylogenetic analysis, functional gene analysis, and pathway analysis).

Results: Phylogenetic case–control association tests showed high abundance of multiple species belonging to the genus Prevotella (but other than previously reported Prevotella copri) in the RA case metagenome. The non-linear machine learning method efficiently deconvoluted the case–control phylogenetic discrepancy. Gene functional assessments showed that the abundance of one redox reaction–related gene was significantly decreased in the RA metagenome compared to controls. A variety of biological pathways including those related to metabolism (e.g., fatty acid biosynthesis and glycosaminoglycan degradation) were enriched in the case–control comparison. A population-specific link between the metagenome and host genome was identified by comparing biological pathway enrichment between the RA metagenome and the RA genome-wide association study (GWAS) results. No apparent discrepancy in alpha- or beta-diversities of metagenome was found between RA cases and controls.

Conclusion: Our shotgun sequencing–based MWAS highlights a novel link among the gut microbiome, host genome, and pathology of RA, which contributes to our understanding of the microbiome’s role in RA etiology.

Phylogenetic tree. Levels L2–L7 are from the inside layer to the outside layer. The size and color of dots represent relative abundance and effect sizes, respectively. The 12 clades with significant case–control associations -q < 0.05- are outlined in red.


Disclosure: T. Kishikawa, None; Y. Maeda, Bristol-Myers Squibb Company, 8, Chugai Pharmaceutical Co. Ltd, 8, Eli Lily, 8, Mitsubishi-Tanabe, 8, Pfizer, 8; T. Nii, None; D. Motooka, None; Y. Matsumoto, None; M. Matsushita, None; H. Matsuoka, None; M. Yoshimura, None; S. Kawada, None; S. Teshigawara, None; E. Oguro, None; Y. Okita, None; K. Kawamoto, None; S. Higa, None; T. Hirano, None; M. Narazaki, None; A. Ogata, None; Y. Saeki, None; S. Nakamura, None; H. Inohara, None; A. Kumanogoh, None; K. Takeda, None; Y. Okada, None.

To cite this abstract in AMA style:

Kishikawa T, Maeda Y, Nii T, Motooka D, Matsumoto Y, Matsushita M, Matsuoka H, Yoshimura M, Kawada S, Teshigawara S, Oguro E, Okita Y, Kawamoto K, Higa S, Hirano T, Narazaki M, Ogata A, Saeki Y, Nakamura S, Inohara H, Kumanogoh A, Takeda K, Okada Y. A Metagenome-wide Association Study of Gut Microbiome Revealed Novel Etiology of Rheumatoid Arthritis in the Japanese Population [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-metagenome-wide-association-study-of-gut-microbiome-revealed-novel-etiology-of-rheumatoid-arthritis-in-the-japanese-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-metagenome-wide-association-study-of-gut-microbiome-revealed-novel-etiology-of-rheumatoid-arthritis-in-the-japanese-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology